Landen CN

No ORCID on file · 3 papers in corpus
2019
Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer.
Cancer research ·doi:10.1158/0008-5472.can-19-0215

Chemoresistance is driven by unique regulatory networks in the genome that are distinct from those necessary for cancer development. Here, we investigate the contribution of enhancer elements to cisplatin resistance in ovarian cancers. Epig…

2016
Metastatic papillary serous uterine cancer presenting as a rash.
Gynecologic oncology reports ·doi:10.1016/j.gore.2016.09.001

BackgroundWe report diagnosis and management of stage IV papillary serous uterine cancer with initial clinical presentation as a skin rash.CaseA 62-year-old postmenopausal female developed an erythematous rash beginning on her right lower a…

2010
Expression of the retinoblastoma-related gene Rb2/p130 in the pathogenesis of serous carcinoma of the ovary.
Applied immunohistochemistry & molecular morphology : AIMM ·doi:10.1097/pai.0b013e3181e78fe0

ObjectiveThe purpose of this study was to evaluate the immunohistochemical Rb2/p130 expression in a series of benign, borderline, and malignant ovarian tumors.Study designSeventy-six operative specimens were analyzed. Frequencies and percen…